Bromhex

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bromhex

Quick Facts

Property Description
Active Ingredient Bromhexine hydrochloride
Forms Tablets, Oral Solution (Syrup/Drops), Injection Solution
Pharmacological Class Mucolytic Agent / Secretolytic Agent
Common Use Addressing conditions with thick, viscous mucus
Origin Synthetic derivative (of the alkaloid vasicine)

What is Bromhexine and Its Pharmacological Identity?

Bromhexine is a synthesized medicinal compound, recognized as a synthetic derivative stemming from chemical modification of the plant alkaloid vasicine, and is primarily classified as a mucolytic agent and secretolytic agent. The active pharmaceutical substance is Bromhexine hydrochloride. This compound is distinguished in its pharmacological class because it serves as the pro-drug for ambroxol, a more potent metabolite that carries out a similar action. This mechanism is clinically recognized for its predictable efficacy in managing respiratory secretions. While the name Bromhexine is the global INN, popular brands featuring this formulation are often positioned for both adult and pediatric patients depending on the specific dosage form. The medication is widely available in forms such as tablets, liquid oral solution (syrups or drops), and specialized solutions for parenteral (injection) administration.

The General Purpose and Action of This Mucus Thinner

The general purpose of Bromhexine is to support airway clearance in individuals experiencing conditions marked by the presence of copious, viscous sputum. Its function as a mucolytic agent directly involves the thinning of thick mucus, ensuring the secretions are less sticky and easier to transport. Bromhexine has an established role in respiratory care where abnormal mucus secretion impairs transport. The conclusion drawn for patients is that this medicine helps the body clear the airways more effectively by thinning the tenacious phlegm, thereby facilitating a more productive cough. This action offers essential support for managing excessive respiratory secretions.

What side effects are possible with Bromhex?

Possible Side Effects and Safety Information

Official regulatory documentation classifies the possible side effects of Bromhexine hydrochloride into frequency bands and System-Organ Classes (SOC). The adverse reactions reported are typically mild, though caution must be exercised regarding serious, rare events.

Frequency-Classified Adverse Reactions

The most frequently classified effects are generally categorized as Uncommon (occurring in fewer than 1 in 100 people). These include disturbances classified under Gastrointestinal disorders, such as nausea, vomiting, diarrhoea, and dyspepsia. Effects on the Nervous System, such as headache and dizziness, are also documented as uncommon.

Reactions involving the Immune System and Skin are typically classified as Rare, including hypersensitivity reactions, rash, and urticaria (hives).

Serious Adverse Reactions and Safety Constraints

The official safety profile mandates awareness of potentially life-threatening reactions, though the frequency is classified as Not Known or Rare. These serious adverse reactions include Anaphylactic reactions (including Anaphylactic shock) and Severe Cutaneous Adverse Reactions (SCARs). SCARs are a group of severe skin conditions that include Erythema multiforme, Stevens-Johnson syndrome (SJS), and Toxic epidermal necrolysis (TEN).

Official labeling requires particular caution when the medicine is used in individuals with a history of peptic ulceration or pre-existing conditions affecting the clearance of metabolites, such as severe hepatic or renal impairment. Furthermore, the safety documentation advises against simultaneous use with cough suppressant medications due to the potential risk of mucus accumulation in the airways.

Overdose and Emergency Response

The official regulatory documents state that no specific overdose syndrome has been reported in man following overexposure to Bromhexine hydrochloride. Observed clinical signs resulting from accidental overdose or medication error are instead consistent with the drug’s known adverse effects. These documented manifestations primarily involve the gastrointestinal system, including symptoms such as nausea, vomiting, upper abdominal pain, and diarrhea, along with generalized symptoms like headache and dizziness.

Regulators document the potential for severe systemic risks that necessitate immediate medical intervention. These serious outcomes include manifestations of hypersensitivity, such as extensive skin rashes and angioedema. Angioedema is characterized by swelling of the face, lips, mouth, tongue, or throat, which may impair breathing. An undesirable increase in the volume of bronchial secretions is also officially listed as a consequence of exceeding therapeutic exposure.

Any suspected overdosage requires immediate medical attention. Regulatory authorities mandate that individuals must immediately telephone a doctor, pharmacist, or the Poisons Information Centre for guidance. The management of overdosage is strictly supportive and focused on symptomatic treatment, as no specific antidote is documented in the official prescribing information reviewed by government agencies.

Therapeutic Uses of Bromhex

What Bromhex Treats: Main Uses and Benefits

Managing Conditions Characterized by Thick, Retained Mucus

This medication is commonly used for symptomatic relief in clinical settings marked by the presence of excessive, viscid, and tenacious sputum, primarily associated with conditions involving inflammatory or irritative processes characterized by periods of heightened symptoms such as those seen in bronchitis and bronchopulmonary issues.

The medication is relevant for managing symptoms that interfere with daily comfort arising from this abnormal mucus secretion. It is relevant in situations involving episodic or fluctuating manifestations like those seen in bronchitis, contributing to improved comfort when secretions are difficult to clear.

Easing the Burden of an Ineffective Productive Cough

The medication is commonly used to help with the symptomatic relief of a chesty cough complicated by symptoms related to physical discomfort and the inability to efficiently expel thick phlegm. By helping to loosen these difficult secretions, it may assist with managing symptoms related to ineffective expectoration, contributing to improved comfort by supporting a less taxing expulsion of phlegm. This use is relevant when short-term symptomatic assistance is needed across typical age groups experiencing symptoms that become more disruptive during flare-ups, such as during seasonal illnesses.


Quick Fact: Symptomatic Management for Thick, Difficult-to-Expel Mucus

Use Context Symptom Addressed Primary Benefit
Acute and Chronic Episodes Viscid Sputum / Chesty Cough Supports General Well-being and Easier Expectoration
Seasonal Illnesses Chest Congestion Assists with Maintaining Functional Stability

Regulatory References

  1. HPRA regulatory authority

Eligibility and Restrictions for Use

Official regulatory bodies define who can and cannot use Bromhexine based on established population eligibility rules. The medicine is contraindicated and must not be used by individuals with a known hypersensitivity to bromhexine or any excipients in the formulation. Some documents also prohibit its use in patients with an active gastroduodenal ulcer.

Age restrictions are strict: use is typically approved for adults and children 12 years and over. Use in children aged 6 to 11 years is often restricted and should be conditional, while the medicine is generally prohibited for children under 6 years of age.

Key restrictions require the use of Bromhexine with caution in patients with severe hepatic impairment or severe renal impairment due to the potential for metabolite accumulation. Caution is also advised for those with a history of gastric ulceration. Additionally, use is not recommended during pregnancy (especially the first trimester) and while breastfeeding, a precautionary stance defined by regulators.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Bromhexine has a limited profile of documented medicinal interactions, which primarily involve certain antibiotics and other cough-relief medications.

Pharmacokinetic Interactions (Antibiotics)

Bromhexine has been shown to increase the concentration of antibiotics in lung tissue and bronchopulmonary secretions. This is considered a pharmacokinetic interaction that facilitates the antibiotic's availability at the site of infection. Specific antibiotics noted in regulatory information include amoxicillin, erythromycin, oxytetracycline, and cefalexine. However, some regulatory bodies also note that no clinically unfavorable interactions have been reported with the co-administration of these antibiotics.

Pharmacodynamic Interactions (Cough Medications)

The combination of bromhexine with other cough suppressants (antitussives) is not recommended. This is a precautionary constraint due to a potential risk of mucus buildup. Since bromhexine thins and loosens mucus, suppressing the cough reflex may lead to an inability to clear the mobilized secretions from the respiratory tract.

General Profile and Precautions

Some official product information states that there are no known significant interactions with other medicines beyond these specific categories. Patients with severe hepatic or renal impairment should be treated with caution, as clearance of bromhexine or its metabolites may be reduced, which is a consideration for its overall pharmacokinetic profile that may affect drug interactions.

Mechanism of Action

Bromhexine's Mechanism of Action

Bromhexine exerts its pharmacodynamic effects primarily through two complementary actions on the respiratory system's secretions and clearance apparatus. The secretolytic action involves the enhancement of lysosomal enzymes within the serous cells of the bronchial glands. This enzymatic activity chemically hydrolyzes and depolymerizes the long-chain acid mucopolysaccharide and mucoprotein fibers that form the structural network of highly viscous mucus. The physiological consequence is a reduction in the viscosity and elasticity of bronchial secretions.

Simultaneously, the drug initiates a secretomotoric action by directly stimulating the ciliated epithelial layer. This stimulation increases the frequency and coordination of ciliary beating, leading to an increase in the rate of mucociliary transport of the thinned secretions toward the pharynx. Separately, the molecule acts as an inhibitor of the host cell protease, Transmembrane Protease Serine 2 (TMPRSS2), interfering with the host cell process required for the activation and cellular entry of certain viruses.

Dosage and Administration Information

Official Administration Guidelines for Bromhexine Hydrochloride

Feature Official Regulatory Rule
Route of Administration Primarily oral (tablets or liquid solution). Parenteral administration (IV/IM) is specified in some regulatory contexts for severe or specialized clinical scenarios.
Standard Dosing Schedule (Adults) The typical maintenance dose for adults and children over 12 is 8 mg three times daily. This may be increased for the initial 7 days to up to 16 mg three times daily (maximum daily dose of 48 mg) in some regions.
Dosing Frequency Administration occurs three times daily (every 8 hours) to ensure a consistent presence of the substance.
Duration of Use Use is intended to be short-term and generally should not exceed seven consecutive days of therapy unless otherwise directed.
Pediatric Rules (Ages 6–11) Children in this age group typically receive 8 mg three times daily, often subject to professional advice.

Procedural and Contextual Instructions

The medicine is designed for use by the oral route, utilizing the available tablet or liquid forms. Liquid solutions must be measured accurately using the measuring device provided to ensure the correct dose is administered. The administration timing is flexible regarding food, as the medicine can be taken with or without a meal. Intravenous solutions must be properly diluted and are specifically restricted from being mixed with alkaline solutions to prevent precipitation.

This instruction set provides a clear framework for standardized use, defining the fixed doses, required frequency, and the general time limit for non-supervised courses of the medicine.

Recent Clinical Evidence

Research evidence / Overview of studies for Bromhexine

This section provides a factual summary of the clinical studies and regulatory research that have explored the use of Bromhexine, focusing on the type of evidence available, the patient groups studied, and the acknowledged gaps in the research. The findings describe group patterns and contribute to understanding symptom patterns, but research does not determine whether an individual will respond similarly.

Evidence for the Management of Chronic Bronchitis

Bromhexine was studied for conditions characterized by fluctuating or episodic manifestations where chronic mucus is a concern, such as stable chronic bronchitis. The initial evidence base is formed by numerous short-term Randomized Controlled Trials (RCTs) and their corresponding systematic reviews.

In these studies, researchers examined outcomes related to physical discomfort by measuring changes in the physical properties of sputum, and monitored patient-reported outcomes describing perceived discomfort. Findings describe patterns observed in the studies related to changes in these sputum characteristics measured during the study period. However, the follow-up durations were limited, meaning long-term effects are not fully established. Evidence quality varies across studies due to methodological differences, and comparative evidence is lacking against the full range of currently available mucoactive agents.

Evidence for Use in Acute Chest Infections

Research also explored the role of Bromhexine for temporary, symptomatic use during acute respiratory illnesses associated with conditions involving periods of heightened symptoms and a chesty cough due to viscous sputum. These studies focused on research exploring short-term symptom changes and examined the time required for symptoms to evolve. When composite measures of overall clinical outcomes were assessed, the findings were mixed across various systematic reviews. Sample sizes were modest in many trials, and evidence quality varies across studies.

Research Gaps and Areas of Uncertainty

Research provides limited information for long-term outcomes that would provide context on the effects of using the medicine continuously for many months or years. In research exploring non-traditional applications—such as in severe systemic viral illnesses—certainty remains low. Comparative evidence is lacking against the full range of currently available mucoactive agents, and subgroup findings are uncertain for many complex patient populations.

Key Studies & References A reappraisal of the mucoactive activity and clinical efficacy of bromhexine

Frequently Asked Questions (FAQ)

Common questions about Bromhex (FAQ)

Q: What is Bromhex used for besides the main condition?

Official regulatory documents describe the purpose of Bromhex as a secretolytic and mucolytic agent. It is intended to help clear mucus in conditions that involve excessive or highly viscous secretions in the respiratory tract. Examples of such uses, described in official product information, include symptoms associated with the common cold, influenza, and specific respiratory tract infections.

Q: Is Bromhex the same type of medicine as a cough syrup?

Bromhex is classified as a mucolytic and secretolytic agent, meaning its primary function is to thin and loosen mucus, rather than suppress the cough itself. Regulatory documents indicate caution when it is taken alongside cough suppressants (antitussives). This is because suppressing the cough reflex may lead to a buildup of the thinned secretions in the airways.

Q: What happens if I miss taking a dose of Bromhex?

Instructions found in official drug literature describe that the dose may be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, regulatory guidance advises skipping the forgotten dose entirely. Regulatory guidance indicates that taking two doses together is typically avoided.

Q: Is it common to feel tired while taking Bromhex?

Official summaries of undesirable effects typically classify effects on the nervous system, such as headache and dizziness, as uncommon. General tiredness or fatigue is not listed among the most frequently reported side effects in the regulatory documentation.

Q: Is Bromhex safe for older adults (seniors)?

Official product information typically lists dosing for adults and children over 12 years of age without defining a separate dose for older adults. Special precautions are only specifically noted for all adults, including seniors, if they have pre-existing severe impairment of the liver or kidneys.

Q: Is Bromhex available over-the-counter or only by prescription?

The regulatory status of Bromhexine hydrochloride varies globally. In some countries, depending on the dosage and formulation, it is available as an over-the-counter (OTC) medication. In other countries, the medication may only be available by prescription.

Q: What happens if someone accidentally takes too much Bromhex?

Official regulatory reports on overdosage note a lack of consistently reported specific, severe symptoms in humans. Symptoms observed in cases of accidental over-exposure are generally consistent with the known side effects of the drug at standard recommended doses, such as those affecting the gastrointestinal system.

Q: Are there generic versions of Bromhex available?

Yes, Bromhexine hydrochloride is the official generic name for the active ingredient. Because it is widely marketed by multiple manufacturers globally, generic versions of the drug in various forms (tablets, liquid) are commonly available.

Q: Does Bromhex interact with alcohol?

Official safety information indicates that consumption of alcohol while using Bromhexine is generally avoided. This precaution is advised because alcohol may potentially increase the risk of side effects such as drowsiness or dizziness.

Q: What if I forget if I already took my dose of Bromhex?

In cases of uncertainty, official dose guidance indicates that taking an extra dose is generally avoided. If it is almost time for the next scheduled dose, regulatory guidance typically suggests skipping the uncertain dose and continuing with the next scheduled dose.

Q: Can Bromhex cause dry mouth?

Official product information typically lists gastrointestinal issues like nausea, vomiting, and diarrhea among the documented side effects. However, dry mouth is generally not explicitly listed among the reported or common adverse effects in regulatory documents.

Q: Are there any known contraindications for people with high blood pressure?

Official contraindications are strict conditions that prohibit the use of the drug. These are generally limited to known hypersensitivity (allergy) to the substance and the presence of an active gastroduodenal ulcer. High blood pressure (hypertension) is not typically listed among these official contraindications.

Q: Does Bromhex have a potential for dependence or misuse?

Based on regulatory information and safety data, Bromhex is generally not considered to be a habit-forming substance. The official safety profile does not indicate a stated potential for dependence or misuse.

Q: Does Bromhex interact with common pain relievers like ibuprofen?

Official drug labels generally describe a limited interaction profile for Bromhex. They state that there are typically no known significant interactions with other medicines beyond the specific categories of certain antibiotics and cough suppressants.

Q: Can I use Bromhex if I am taking blood pressure medication?

Official regulatory documents generally describe that there are no known significant interactions with other types of medications outside of the specific cautions concerning certain antibiotics and cough suppressants.

Q: What is the difference between Bromhex and another common similar-sounding drug?

Bromhex is classified as a mucolytic agent that works to thin and loosen mucus in the airways. It is distinguished from other agents because it acts as the pro-drug for the active metabolite ambroxol. This mechanism is different from that of cough suppressants, which act to block the cough reflex.

Q: Does Bromhex make you feel drowsy or affect driving?

Official safety information notes that in some individuals, Bromhex may cause side effects such as dizziness or drowsiness. Official warnings state that driving or operating hazardous machinery may be affected, and caution should be exercised if dizziness or drowsiness is experienced.

Q: Are there different strengths or forms of Bromhex available?

Official documents define different available pharmaceutical forms, which include tablets and oral solutions (such as syrups). These forms are available in varying concentrations to accommodate appropriate dosing for different populations, including children over the specified age and adults.

Q: Can Bromhex interfere with birth control pills?

Official drug labels generally state that there are no known significant interactions with other medicines. The only specific interaction categories typically noted are certain antibiotics and cough suppressants.

Q: Why is Bromhex not recommended for very young children?

Regulatory bodies typically prohibit or restrict the use of Bromhex for children under 6 years of age. This restriction is based on caution regarding pediatric safety, as official posology (dosing) and detailed safety data are often limited for this young age group.

Q: What is the reason for the age restriction on Bromhex use?

Official posology guidelines generally prohibit the use of this drug in children under 6 years of age in many regions. The restriction is primarily based on caution regarding pediatric safety, as the official data regarding efficacy and side effects is limited or not established for this very young age group.

Q: How is Bromhex processed by the body?

Official pharmacokinetic descriptions indicate that Bromhex is highly absorbed and rapidly metabolized in the body. It is also described as a pro-drug for ambroxol. Regulatory documents highlight that its clearance requires caution in patients with severe hepatic (liver) or renal (kidney) impairment.

Q: Is Bromhex approved by major regulatory bodies globally?

Yes, Bromhex is widely approved and regulated globally, with its official product information maintained and monitored by numerous international regulatory bodies. These include major health authorities in Europe, Australia, and various national drug agencies.

Q: Can Bromhex be used safely alongside other cold and flu medications?

Official product information advises specific caution against using Bromhex alongside cold and flu medications that contain cough suppressants (antitussives). This is to avoid the theoretical risk of having thinned mucus accumulate in the airways when the ability to cough is blocked.

How should Bromhex be stored and disposed of?

Storage and Disposal of Bromhexine

Official labeling mandates specific conditions to maintain the stability and integrity of bromhexine products.

Storage Requirements

Condition Regulatory Requirement
Temperature Store at ambient temperature, not exceeding 30°C; must not freeze
Protection Keep in a dry place and protect from light (e.g., store in the original, tightly closed container)
Child Safety Mandatory to keep the medicine out of the sight and reach of children
Stability Oral solutions may have a defined in-use stability period (e.g., six months) after the container is first opened

Disposal Instructions

Unused or expired bromhexine product must be discarded in accordance with local regulations for pharmaceutical waste. The preferred method is to utilize a community drug take-back program. Disposal down drains or into water courses is generally restricted.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bromhex found in:

A-Z Index: